2022. Randomized trials - Ivermectin repurposing for COVID-19 treatment of outpatients with mild disease in primary health care centers. Research, Society and Development. 11, 8 (Jun. 2022), e35511830844. DOI:https://doi.org/10.33448/rsd-v11i8.30844.